» Articles » PMID: 32548292

Radiomic Features of Multiparametric MRI Present Stable Associations With Analogous Histological Features in Patients With Brain Cancer

Overview
Journal Tomography
Publisher MDPI
Specialty Radiology
Date 2020 Jun 18
PMID 32548292
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Magnetic resonance (MR)-derived radiomic features have shown substantial predictive utility in modeling different prognostic factors of glioblastoma and other brain cancers. However, the biological relationship underpinning these predictive models has been largely unstudied, and the generalizability of these models had been called into question. Here, we examine the localized relationship between MR-derived radiomic features and histology-derived "histomic" features using a data set of 16 patients with brain cancer. Tile-based radiomic features were collected on T1, post-contrast T1, FLAIR, and diffusion-weighted imaging (DWI)-derived apparent diffusion coefficient (ADC) images acquired before patient death, with analogous histomic features collected for autopsy samples coregistered to the magnetic resonance imaging. Features were collected for each original image, as well as a 3D wavelet decomposition of each image, resulting in 837 features per MR and histology image. Correlative analyses were used to assess the degree of association between radiomic-histomic pairs for each magnetic resonance imaging. The influence of several confounds was also assessed using linear mixed-effect models for the normalized radiomic-histomic distance, testing for main effects of different acquisition field strengths. Results as a whole were largely heterogeneous, but several features showed substantial associations with their histomic analogs, particularly those derived from the FLAIR and postcontrast T1W images. These features with the strongest association typically presented as stable across field strengths as well. These data suggest that a subset of radiomic features can consistently capture texture information on underlying tissue histology.

Citing Articles

Radiomics in radiology: What the radiologist needs to know about technical aspects and clinical impact.

Ferrari R, Trinci M, Casinelli A, Treballi F, Leone E, Caruso D Radiol Med. 2024; 129(12):1751-1765.

PMID: 39472389 DOI: 10.1007/s11547-024-01904-w.


Multimodal deep learning improves recurrence risk prediction in pediatric low-grade gliomas.

Mahootiha M, Tak D, Ye Z, Zapaishchykova A, Likitlersuang J, Climent Pardo J Neuro Oncol. 2024; 27(1):277-290.

PMID: 39211987 PMC: 11726244. DOI: 10.1093/neuonc/noae173.


Advances in Molecular Pathology, Diagnosis and Treatment of Spinal Cord Astrocytomas.

Zhao Z, Song Z, Wang Z, Zhang F, Ding Z, Fan T Technol Cancer Res Treat. 2024; 23:15330338241262483.

PMID: 39043042 PMC: 11271101. DOI: 10.1177/15330338241262483.


Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Radiomic Models in Prostate Cancer Prognostication.

Huynh L, Swanson S, Cima S, Haddadin E, Baine M Cancers (Basel). 2024; 16(10).

PMID: 38791977 PMC: 11120365. DOI: 10.3390/cancers16101897.


Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response.

Bobholz S, Hoefs A, Hamburger J, Lowman A, Winiarz A, Duenweg S J Neurooncol. 2024; 167(2):233-241.

PMID: 38372901 PMC: 11024025. DOI: 10.1007/s11060-024-04593-7.


References
1.
Galla N, Chiang G, Chakraborty S, Singh R, Tsiouris A, Boockvar J . Apparent diffusion coefficient changes predict survival after intra-arterial bevacizumab treatment in recurrent glioblastoma. Neuroradiology. 2017; 59(5):499-505. DOI: 10.1007/s00234-017-1820-4. View

2.
Gillies R, Kinahan P, Hricak H . Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2015; 278(2):563-77. PMC: 4734157. DOI: 10.1148/radiol.2015151169. View

3.
McGarry S, Hurrell S, Iczkowski K, Hall W, Kaczmarowski A, Banerjee A . Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018; 101(5):1179-1187. PMC: 6190585. DOI: 10.1016/j.ijrobp.2018.04.044. View

4.
Ellingson B, Kim H, Woodworth D, Pope W, Cloughesy J, Harris R . Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology. 2014; 271(1):200-10. PMC: 4263651. DOI: 10.1148/radiol.13131305. View

5.
Prah M, Al-Gizawiy M, Mueller W, Cochran E, Hoffmann R, Connelly J . Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics. J Neurooncol. 2017; 136(1):13-21. PMC: 5756123. DOI: 10.1007/s11060-017-2617-3. View